返回
CARsgen Therapeutics Holdings Limited（02171.HK）价格
02171.HK 股价走势图
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$14.85
-0.33%
$-0.05
盘中： Feb 16, 10:26:03 HKT
关键数据
前收盘价
$14.4
开盘价
$14.9
当日区间
$14.44 - $15.52
52周范围
$9.44 - $25.6
交易量
489.5K
平均成交量
1.6M
每股收益（TTM）
-1.07
股息收益率
--
市值
$8.1B
什么是 CARSGEN-B？
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.